Debora Degl’Innocenti

1.1k total citations
14 papers, 891 citations indexed

About

Debora Degl’Innocenti is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Oncology. According to data from OpenAlex, Debora Degl’Innocenti has authored 14 papers receiving a total of 891 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 7 papers in Endocrinology, Diabetes and Metabolism and 4 papers in Oncology. Recurrent topics in Debora Degl’Innocenti's work include Thyroid Cancer Diagnosis and Treatment (7 papers), Wnt/β-catenin signaling in development and cancer (5 papers) and Digestive system and related health (3 papers). Debora Degl’Innocenti is often cited by papers focused on Thyroid Cancer Diagnosis and Treatment (7 papers), Wnt/β-catenin signaling in development and cancer (5 papers) and Digestive system and related health (3 papers). Debora Degl’Innocenti collaborates with scholars based in Italy, Finland and United States. Debora Degl’Innocenti's co-authors include Maria Grazia Borrello, Marco A. Pierotti, Giuliana Cassinelli, Angela Greco, Laura Fugazzola, Silvana Pilotti, Luisella Alberti, Cristina Ferrario, Paola Collini and Andrew H. Fischer and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Oncogene.

In The Last Decade

Debora Degl’Innocenti

14 papers receiving 875 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Debora Degl’Innocenti Italy 12 387 313 308 230 179 14 891
Cinzia Puppin Italy 23 782 2.0× 360 1.2× 369 1.2× 155 0.7× 220 1.2× 46 1.2k
Farideh Miraki‐Moud United Kingdom 19 583 1.5× 321 1.0× 295 1.0× 259 1.1× 264 1.5× 33 1.4k
Hironao Yasuoka Japan 19 619 1.6× 197 0.6× 773 2.5× 127 0.6× 202 1.1× 58 1.2k
Jung Hun Song South Korea 10 384 1.0× 321 1.0× 285 0.9× 67 0.3× 92 0.5× 10 757
Françoise Descôtes France 20 593 1.5× 213 0.7× 342 1.1× 83 0.4× 326 1.8× 66 1.2k
Tamara Aleksic United Kingdom 15 454 1.2× 258 0.8× 245 0.8× 47 0.2× 219 1.2× 18 786
Claudia Miranda Italy 22 776 2.0× 301 1.0× 410 1.3× 113 0.5× 207 1.2× 33 1.5k
Thomas Strömberg Sweden 12 503 1.3× 168 0.5× 214 0.7× 85 0.4× 151 0.8× 15 744
Heather Hardin United States 19 595 1.5× 257 0.8× 246 0.8× 56 0.2× 483 2.7× 31 966
Alfredo Romano Italy 6 706 1.8× 236 0.8× 253 0.8× 54 0.2× 153 0.9× 8 1.0k

Countries citing papers authored by Debora Degl’Innocenti

Since Specialization
Citations

This map shows the geographic impact of Debora Degl’Innocenti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Debora Degl’Innocenti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Debora Degl’Innocenti more than expected).

Fields of papers citing papers by Debora Degl’Innocenti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Debora Degl’Innocenti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Debora Degl’Innocenti. The network helps show where Debora Degl’Innocenti may publish in the future.

Co-authorship network of co-authors of Debora Degl’Innocenti

This figure shows the co-authorship network connecting the top 25 collaborators of Debora Degl’Innocenti. A scholar is included among the top collaborators of Debora Degl’Innocenti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Debora Degl’Innocenti. Debora Degl’Innocenti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Pellegrini, Cinzia, Anna Dodero, Annalisa Chiappella, et al.. (2016). A phase II study on the role of gemcitabine plus romidepsin (GEMRO regimen) in the treatment of relapsed/refractory peripheral T-cell lymphoma patients. Journal of Hematology & Oncology. 9(1). 38–38. 36 indexed citations
2.
Minna, Emanuela, Paola Romeo, Loris De Cecco, et al.. (2014). miR-199a-3p displays tumor suppressor functions in papillary thyroid carcinoma. Oncotarget. 5(9). 2513–2528. 97 indexed citations
3.
Degl’Innocenti, Debora, Paola Romeo, Eva Tarantino, et al.. (2012). DUSP6/MKP3 is overexpressed in papillary and poorly differentiated thyroid carcinoma and contributes to neoplastic properties of thyroid cancer cells. Endocrine Related Cancer. 20(1). 23–37. 45 indexed citations
4.
Borrello, Maria Grazia, Antonella Aiello, Bernard Peissel, et al.. (2011). Functional characterization of the MTC-associated germline RET-K666E mutation: evidence of oncogenic potential enhanced by the G691S polymorphism. Endocrine Related Cancer. 18(4). 519–527. 22 indexed citations
5.
Degl’Innocenti, Debora, Giancarlo Castellano, Angela Greco, et al.. (2010). Integrated Ligand-Receptor Bioinformatic and In Vitro Functional Analysis Identifies Active TGFA/EGFR Signaling Loop in Papillary Thyroid Carcinomas. PLoS ONE. 5(9). e12701–e12701. 32 indexed citations
6.
Muzza, Marina, Debora Degl’Innocenti, Carla Colombo, et al.. (2010). The tight relationship between papillary thyroid cancer, autoimmunity and inflammation: clinical and molecular studies. Clinical Endocrinology. 72(5). 702–708. 138 indexed citations
7.
Cassinelli, Giuliana, Enrica Favini, Debora Degl’Innocenti, et al.. (2009). RET/PTC1-Driven Neoplastic Transformation and Proinvasive Phenotype of Human Thyrocytes Involve Met Induction and β-Catenin Nuclear Translocation. Neoplasia. 11(1). 10–21. 50 indexed citations
8.
Muzza, Marina, Debora Degl’Innocenti, Carla Colombo, et al.. (2009). The tight relationship between papillary thyroid cancer, autoimmunity and inflammation: clinical and molecular studies. Clinical Endocrinology. 9 indexed citations
9.
Borrello, Maria Grazia, Debora Degl’Innocenti, & Marco A. Pierotti. (2008). Inflammation and cancer: The oncogene-driven connection. Cancer Letters. 267(2). 262–270. 91 indexed citations
10.
Pierotti, Marco A., Elena Arighi, Debora Degl’Innocenti, & Maria Grazia Borrello. (2006). Ret Activation in Medullary Carcinomas. Kluwer Academic Publishers eBooks. 122. 389–415. 1 indexed citations
11.
Borrello, Maria Grazia, Luisella Alberti, Andrew H. Fischer, et al.. (2005). Induction of a proinflammatory program in normal human thyrocytes by the RET/PTC1 oncogene. Proceedings of the National Academy of Sciences. 102(41). 14825–14830. 264 indexed citations
12.
Degl’Innocenti, Debora, Elena Arighi, Luisella Alberti, et al.. (2004). Differential requirement of Tyr1062 multidocking site by RET isoforms to promote neural cell scattering and epithelial cell branching. Oncogene. 23(44). 7297–7309. 21 indexed citations
13.
Arighi, Elena, Debora Degl’Innocenti, Maria Grazia Borrello, et al.. (2004). Biological Effects of the Dual Phenotypic Janus Mutation of ret Cosegregating with Both Multiple Endocrine Neoplasia Type 2 and Hirschsprung’s Disease. Molecular Endocrinology. 18(4). 1004–1017. 54 indexed citations
14.
Borrello, Maria Grazia, Carla Perego, Debora Degl’Innocenti, et al.. (2002). Differential interaction of Enigma protein with the two RET isoforms. Biochemical and Biophysical Research Communications. 296(3). 515–522. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026